Ignite Creation Date:
2024-05-05 @ 11:47 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00130078
Status:
UNKNOWN
Last Update Posted:
2005-09-26
First Post:
2005-08-11
Brief Title:
Trial of SAVVY Vaginal Gel and HIV in Nigeria
Sponsor:
Biosyn
Organization:
Biosyn
Study Overview
Official Title:
Randomized Controlled Trial of SAVVY and HIV in Nigeria
Status:
UNKNOWN
Status Verified Date:
2005-08
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Heterosexual contact is now the primary route of transmission for HIV worldwide This study is a phase 3 trial designed to determine the effectiveness and safety of the 10 C31G SAVVY vaginal gel for the prevention of male-to-female transmission of HIV among women at high risk
Detailed Description:
Heterosexual contact is now the primary route of transmission for HIV worldwide This study is a phase 3 multi-center fully-masked randomized placebo controlled trial designed to determine the effectiveness and safety of the 10 C31G SAVVY vaginal gel for the prevention of male-to-female transmission of HIV among women at high risk
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None